Results 201 to 210 of about 383,545 (266)

Systemic Treatments for Recurrent or Metastatic Sinonasal Carcinomas: A Retrospective Multicenter Study

open access: yesHead &Neck, EarlyView.
ABSTRACT Introduction Sinonasal cancers are rare and heterogeneous and pose a therapeutic challenge at an advanced stage due to the lack of data on appropriate systemic management. Methods This retrospective multicenter study analyzed 83 patients with recurrent or metastatic sinonasal carcinomas ineligible for curative treatment, treated in France ...
Marie Degrange   +16 more
wiley   +1 more source

CXCL10 as a migration-associated biomarker in oral squamous cell carcinoma. [PDF]

open access: yesBMC Oral Health
Sun YS   +4 more
europepmc   +1 more source

Treatment‐Related Adverse Events and Health‐Related Quality of Life Associated With Immune Checkpoint Inhibitor Treatment for Mucosal Head and Neck Squamous Cell Carcinoma: A Scoping Review

open access: yesHead &Neck, EarlyView.
ABSTRACT Background Supportive care needs of patients receiving immune checkpoint inhibitors (ICIs) for head and neck squamous cell carcinoma (HNSCC) are ill‐defined. Hence, known treatment‐related adverse events (TRAEs) and health‐related quality of life (HRQoL) associated with ICI treatment for HNSCC were examined to inform future supportive care ...
N. D. O'Donnell   +11 more
wiley   +1 more source

Characterization of a single liver cystic mass: a metastasis of squamous cell carcinoma of the nasopharynx. [PDF]

open access: yesInt J Surg Case Rep
Chaabouni A   +5 more
europepmc   +1 more source

Inhibitory role of angiopoietin‑like 4 for cancer progression in oropharyngeal squamous cell carcinoma. [PDF]

open access: yesOncol Rep
Mikoshiba T   +7 more
europepmc   +1 more source

Significance of Methyltransferase-like 5 Expression in Oral Squamous Cell Carcinoma. [PDF]

open access: yesInt Dent J
Kajiya Y   +7 more
europepmc   +1 more source

Metformin Use and Development of Esophageal Squamous Cell Carcinoma.

open access: yesJAMA Netw Open
Xie SH   +6 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy